Siemens PTH Quality Control

Home - Immunoassay

Siemens PTH Quality Control

Therapeutic Drug Quality Control

Providing a true third party solution for the measurement of PTH, the Acusera PTH Control has been optimised for use with Siemens instruments to provide an unbiased, independent assessment of laboratory performance.

This notoriously unstable marker, present in a number of immunoassay controls, is available in a liquid frozen format with an impressive 30 day open vial stability, reducing waste while remaining easy-to-use.

Siemens Advia Centaur XPT (pg/ml) Range
Level One 21 (13 – 29)
Level Two 153 (104 – 202)
Level Three 435 (296 – 574)

Features & Benefits

  • Liquid frozen
  • Human serum based
  • Assayed target values are assigned for Siemens analysers
  • Stable to expiry date at -20°C to 70°C
  • Open vial stability of 30 days at 2°C to 8°C
DescriptionSizeAnalytesCat No
PTH Control Level 13 x 2 ml1PTH10530
PTH Control Level 23 x 2 ml1PTH10531
PTH Control Level 33 x 2 ml1PTH10532


  • PTH (Parathyroid Hormone)

Related Products



Randox’s antigen-HRP conjugates are optimized for use with Randox polyclonal antibodies for the development of immunoassays. All HRP-conjugates are provided in a conjugate stabilising solution, specifically formulated in-house to prolong the shelf-life of newly conjugated material, enhancing the conjugate’s overall performance and reliability within your immunoassay.

Product NameCat NumberSize
3-Acetyl-DON HRP97110.5ml
4-AHD (Aminohydantoin)HRP92550.5ml
5-Hydroxyindole Acetic AcidHRP94760.5ml
17α-Nortestosterone HRP93090.5ml
17α-Boldenone HRP92470.5ml
17α-Boldenone HRP92460.5ml
17α-Estradiol HRP92590.5ml
17α HydroxyprogesteroneHRP94140.5ml
17α-Testosterone HRP92600.5ml
17α-Trenbolone HRP92440.5ml
17β-Boldenone HRP92480.5ml
17β-Estradiol HRP93520.5ml
17β-Estradiol-short linkerHRP93510.5ml
17β-Testosterone HRP92280.5ml
17β-Trenbolone HRP92450.5ml
17β-Nortestosterone HRP93690.5ml
Acepromazine HRP94690.5ml
Albendazole HRP92190.5ml
Albendazole HRP96050.5ml
Androstenedione HRP93070.5ml
Avilamycin HRP96150.5ml
Azaperone HRP95030.5ml
Benzimidazole HRP94090.5ml
Carazolol HRP96240.5ml
Carbadox HRP92710.5ml
Carbamazepine HRP94980.5ml
Carbamazepine HRP95110.5ml
Carboxymethyl LSD HRP94810.5ml
Cephalexin HRP96420.5ml
Chlormadinone Acetate HRP92300.5ml
Chlorpromazine HRP94570.5ml
Cimaterol HRP94100.5ml
Closantel HRP96170.5ml
Cocaine HRP95240.5ml
Cocaine/Benzoylecgonine HRP93360.5ml
Cotinine HRP94780.5ml
Cortisol HRP92860.5ml
Creatinine Acid HRP94770.5ml
Cyclic AMPHRP93710.5ml
Dehydronorketamine HRP95130.5ml
Dehydroepiandrosterone Sulphate (DHEA)HRP96480.5ml
Demethyl Salvinorin HRP94800.5ml
Deoxynivalenol HRP97100.5ml
Desmethylnaproxen HRP95170.5ml
Desmycosin HRP96770.5ml
Dextromethorphan HRP95000.5ml
Dehydroepiandrosterone (DHEA) HRP96180.5ml
Dehydroepiandrosterone (DHEA-17) HRP92410.5ml
Diclazuril HRP92800.5ml
Dicloxicillin HRP96030.5ml
Dienestrol (p-OH) HRP92580.5ml
Diethylstilbestrol HRP95140.5ml
Digoxin HRP94700.5ml
Digoxigenin HRP94310.5ml
Dihydrotestosterone HRP93060.5ml
Dinitrosalicylic Acid Hydrazide (DNSH) HRP93960.5ml
Dipyrone HRP92850.5ml
Epiandrosterone HRP93080.5ml
EPI-Demethyl Salvinorin HRP95020.5ml
Epitestosterone HRP96020.5ml
Ergot Alkaloids HRP97080.5ml
Ergot Alkaloids HRP97090.5ml
Erythromycin HRP96010.5ml
Escitalopram HRP94600.5ml
Estriol HRP94650.5ml
Estriol (6) HRP94000.5ml
Estriol (6a) HRP93990.5ml
Ethinylestradiol HRP92350.5ml
Ethyl Glucuronide HRP95310.5ml
Etodolac HRP93420.5ml
Fentanyl HRP96260.5ml
Florfenicol HRP94070.5ml
Flunixin HRP93410.5ml
Flumequine HRP92540.5ml
Fumonisin HRP97130.5ml
Gentamycin HRP96090.5ml
Gestrinone HRP94270.5ml
Halofuginone HRP96730.5ml
Haloperidol HRP94960.5ml
Heroin HRP94990.5ml
Hydrocodone HRP93010.5ml
Hydromorphone HRP92890.5ml
17α HydroxyprogesteroneHRP96470.5ml
Hygromycin B HRP96760.5ml
Ibuprofen HRP96750.5ml
Isoxsuprine HRP92640.5ml
JWH-018 HRP95220.5ml
JWH-018 HRP95230.5ml
Kanamycin HRP92220.5ml
Kebuzone HRP93450.5ml
Ketamine HRP96740.5ml
Ketamine HRP95180.5ml
Ketoprofen HRP93430.5ml
Lasalocid HRP92780.5ml
Leucomalachite Green HRP92670.5ml
Lidocaine HRP95260.5ml
Lidocaine HRP96200.5ml
Lorazepam HRP96070.5ml
Lysergic Acid Diethylamide (LSD)HRP94610.5ml
Maduramicin HRP96000.5ml
MDMA HRP96210.5ml
Medroxyprogesterone Acetate HRP92330.5ml
Megestrol Acetate HRP92320.5ml
Megestrol HRP93530.5ml
Melengestrol AcetateHRP92310.5ml
Meloxicam HRP93900.5ml
Meperidine-Normeperidine HRP93020.5ml
Meprobamate HRP94560.5ml
Mescaline HRP94470.5ml
Mestanolone HRP94020.5ml
Methamphetamine HRP94670.5ml
Methamphetamine HRP97200.5ml
Methandriol HRP92390.5ml
Methcathinone HRP95350.5ml
Methylphenidate HRP96270.5ml
Methylprednisolone HRP93910.5ml
Methyltestosterone HRP92370.5ml
Monensin HRP92920.5ml
Morphine-6-Hemisuccinate HRP94950.5ml
Mycophenolic AcidHRP94320.5ml
Nalidixic Acid HRP93460.5ml
Naltrexone HRP94540.5ml
Neomycin HRP92250.5ml
Nicarbazin HRP92790.5ml
Nitrazepam HRP94580.5ml
Norescitalopram HRP94590.5ml
Norfentanyl HRP95390.5ml
Norfentanyl HRP94750.5ml
Norfluoxetine HRP94620.5ml
Norsertraline HRP94970.5ml
Ochratoxin A HRP97070.5ml
Olaquindox HRP95200.5ml
Olaquindox HRP95270.5ml
Oxazepam HRP94790.5ml
Oxazepam HRP96610.5ml
Oxolinic Acid HRP92960.5ml
Oxyphenbutazone HRP93440.5ml
Phenobarbital HRP96700.5ml
Phenytoin HRP94180.5ml
Pirlimycin HRP94060.5ml
Prednisolone HRP96360.5ml
Procainamide HRP96380.5ml
Progesterone HRP92610.5ml
Quinidine HRP96860.5ml
Ractopamine HRP92510.5ml
Ractopamine HRP92520.5ml
Ritodrine HRP92660.5ml
Robenidine HRP96040.5ml
Ronidazole HRP92530.5ml
Ronidazole HRP96800.5ml
Salicyclic AcidHRP95050.5ml
Salinomycin HRP95190.5ml
Salmeterol HRP93980.5ml
Salvinorin HRP94710.5ml
Secobarbital HRP96720.5ml
Sirolimus HRP96790.5ml
Spectinomycin HRP95250.5ml
Stanozolol HRP94660.5ml
Sulphabenzamide HRP94080.5ml
Sulphaguanidine HRP92680.5ml
Sulphaphenazole HRP92930.5ml
Theophylline HRP95370.5ml
Thiabendazole HRP92830.5ml
Tolfenamic Acid HRP94050.5ml
Toltrazuril HRP93970.5ml
Tacrolimus HRP94240.5ml
Tacrolimus HRP94250.5ml
Trazodone HRP94510.5ml
Trazodone HRP94520.5ml
Triamcinolone HRP96250.5ml
Triamcinolone Acetonide HRP95010.5ml
Triclabendazole HRP93950.5ml
Trimethoprim HRP92940.5ml
Urochloralic Acid HRP94740.5ml
Venlafaxine HRP96850.5ml
Warfarin HRP96080.5ml
Zaleplon HRP94480.5ml
Zearalenone HRP97120.5ml
Zilpaterol HRP92650.5ml
Zolpidem HRP95080.5ml
Zopiclone HRP95060.5ml



Our Range of BioReagents

COVID-19 Cytokine Testing Solutions

Randox Logo

COVID-19 Risk Stratification & Treatment Monitoring

Randox Cytokine Testing Solutions

COVID-19 Risk Stratification and Treatment Monitoring

  • null
    Simultaneous detection of up to 12 cytokines and growth factors from a single patient sample
  • null
    Suitable for use with serum and plasma samples
  • null
    Fully automated and semi-automated solutions available to suit all laboratory throughputs
  • null
    Excellent analytical performance
  • null
    Comprehensive test menu comprising 26 cytokines, cytokine receptors and growth factors
  • null
    Availability of complementary quality controls for a complete testing package

Randox offer testing solutions for a comprehensive range of cytokines, cytokine receptors and growth factors designed to assist with COVID-19 risk stratification, monitoring of treatment efficacy and recovery. Utilising patented Biochip technology up to 12 cytokines and growth factors may be detected simultaneously from a single patient sample.

Cytokines play a vital role in the immune system and are known to be involved in the body’s response to a variety of inflammatory and infectious diseases. The over stimulation of these cytokines in response to infection is referred to as a ‘cytokine storm’ and strongly correlates with poor disease outcomes.

Cytokine storms are a common complication of SARS-CoV-2 (COVID-19) infection triggering viral sepsis, where viral replication and excessive, uncontrolled systemic inflammation may lead to pneumonitis, Acute Respiratory Distress Syndrome (ARDS), respiratory failure, shock, multiple organ failure, secondary bacterial pneumonia, and potentially death.





Cytokine Array I (12-plex)

  • IL-1α
  • IL-1β
  • IL-2
  • IL-4
  • IL-6
  • IL-8
  • IL-10
  • IFNγ
  • EGF
  • MCP-1
  • TNFα
  • VEGF

Interleukin-1 (IL-1) is a regulatory and inflammatory cytokine, which exists in two forms, (IL-1α) and (IL-1β), which share 25% homology at amino acid level. IL-1α is produced as a biologically active 31 kDa precursor, which undergoes proteolytic cleavage yielding a 17 kDa protein of 159 amino acids.

There are two forms of IL-1, IL-1α and IL-1β ,which share 25% homology at amino acid level. IL-1β is synthesised as a biologically inactive precursor of 269 amino acids with a molecular mass of 31 kDa , which undergoes proteolytic cleavage by IL1 converting enzyme (ICE), which yields a 17kDa protein of 153 amino acids.

Interleukin-2 (IL-2) is an interleukin, a type of cytokine signaling molecule in the immune system. It is a 15 – 18 kDa protein which has varying degrees of glycosylation accounting for the observed molecular weight range. IL-2 regulates the activities of white blood cells (leukocytes, often lymphocytes) that are responsible for immunity.

IL-4 is a glycoprotein synthesised as a precursor protein of 153 amino acids. The first 24 amino acid residue signal peptide is cleaved to produce a 129 amino acid 15-19 kDa protein.

IL-6 is synthesised as a precursor protein of 212 amino acids. The N-terminal 28 amino acid residue signal peptide is cleaved to produce a 21kDa protein. It has two potential N-glycosylation sites which have no effect on bioactivity. Different post-translational alterations such as glycosylation and phosphorylation give various forms of IL-6 with molecular masses of 21.5-28 kDa. The IL-6 receptor is a strongly glycosylated 80 kDa protein of 449 amino acids. Two different forms of the receptor have been described that bind IL-6 with differing affinities, a soluble form of the IL-6 receptor has also been described. The IL-6 receptor is expressed on T cells, mitogen activated B cells, peripheral monocytes and some macrophage and B cell derived tumour cell types. IL-6 also influences antigen-specific immune responses and inflammatory reactions.

IL-8 is a member of a structurally similar family of cytokines called chemokines, which demonstrate chemotactic activity for neutrophils. IL-8 is a non-glycosylated protein of 8 kDa and consists of 99 amino acids with a 22 residue signal peptide that is cleaved to generate a 77 amino acid sequence. IL-8 is produced in response to proinflammatory stimuli. It is produced by monocytes, macrophages, fibroblasts, endothelial cells, keratinocytes, melanocytes, hepatocytes, chondrocytes, T-cells, neutrophils, and astrocytes.

Interleukin-10 (IL-10), alternatively known as B-cell-derived T-cell growth factor (B-TCGF), cytokine synthesis inhibitory factor (CSIF) or T-cell growth inhibitory factor is a homodimeric protein with a molecular weight of 18 kDa. It is produced as a 178 amino acid residue precursor, which is cleaved to give a mature protein of 160 amino acids. IL-10’s primary function is as an anti-inflammatory agent, which inhibits cytokine production by T cells and natural killer cells caused by activation of monocytes/macrophages.

IFN-γ is a cytokine critical to both innate and adaptive immunity, and functions as the primary activator of macrophages, in addition to stimulating natural killer cells and neutrophils. Biologically active interferon gamma is a 20 or 25 kDa glycoprotein depending on its glycosylation state. This lymphokine is synthesised as a 166 amino acid sequence but is cleaved to give a 143 amino acid residue.

Human EGF is produced as a long precursor protein of 1207 amino acids which is released by proteolytic cleavage to give a globular protein of 6.4 kDa consisting of 53 amino acids. EGF is a common mitogenic factor that stimulates the proliferation of different types of cells, especially fibroblasts and epithelial cells. EGF activates the EGF receptor (EGFR/ErbB), which initiates, in turn, intracellular signaling.

Monocyte chemoattractant protein (MCP-1) is part of the chemotactic family of cytokines called chemokines. ). It is a 76 amino acid peptide and has a molecular weight of 8.6 kDa. MCP-1 in particular chondrocytes confirming its role in inflammatory responses. MCP-1 has been implicated in a wide variety of inflammatory diseases such as artherosclerosis, delayed hypersensitivity reactions, rheumatoid arthritis, alveotitis and idiopathic pulmonary fibrosis.

Tumour necrosis factor alpha (TNFα) is a 157 amino acid 26 kDa transmembrane protein which is secreted as a soluble mature 233 amino acid homotrimer of 17 kDa by proteolytic cleavage. TNF-α is secreted by macrophages in response to stimuli for the induction of systemic inflammation. The binding of the ligand TNF-α to the TNF receptor (TNFR1) initiates the pro-inflammatory and pro-apoptotic signaling cascades.

Vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF), is secreted as a glycosylated homodimeric protein of 46 kDa that is made up of two 24 kDa subunits linked by disulphide bonds. VEGF is expressed by vascularised tissue such as pituitary, brain, lungs, kidneys, heart and adrenal glands, although it is assumed that all tissues have the potential to produce the growth factor. VEGF is stimulated when cells become deficient in oxygen or glucose or under inflammatory conditions.

Ordering Information


Cat. NumberDescriptionKit Size
EV3508Cytokine Array I Evidence360 Biochips
EV3544Cytokine Array I Evidence180 Biochips
EV3513Cytokine Array I Evidence Investigator54 Biochips
EV3623Cytokine Array I High Sensitivity Evidence Investigator54 Biochips

Cytokine Array III (4-plex)

  • IL-5
  • IL-15
  • GM-CSF
  • MIP-1 α

Interleukin-5 (IL-5) is a disulphide linked homodimer and belongs to a family of structurally related proteins that includes: interleukin-2, interleukin-4, macrophage colony-stimulating factor, granulocyte macrophage colony-stimulating factor and growth hormone. It is a glycoprotein with the apparent molecular weight of recombinant IL-5 produced by mammalian cells in the range 45 to 60 kDa. The large variation in the molecular weight caused predominantly by the addition of heterogeneous carbohydrate chains.

Interleukin-15 (IL-15) is a 14 to 15 kDa protein of 114 amino acids. It contains 2 disulphide bonds and 2 N-linked glycosylation sites at the C-terminus1. IL-15 is expressed at the mRNA level in numerous normal human tissues in a broad range of cell types, including activated monocytes, dendritic cells, osteoclasts and fibroblasts. IL-15 has an essential role in natural killer (NK) cell development. It activates NK cell proliferation, cytotoxicity, and cytokine production and regulates NK cell/macrophage interaction. Studies have suggested that IL-15 may have a role in establishing innate immune responses and maintaining neutrophil-mediated inflammatory processes.

Granulocyte-macrophage colony stimulating factor (GMCSF) isolated from human sources is glycosylated with an apparent molecular mass of 23 kDa. The mature protein has 127 amino acids and is preceded by a hydrophobic leader sequence of 25 amino acids.

Macrophage inflammatory protein-1α (MIP-1α, CCL3) is a member of the CC chemokine subfamily whose members are known for chemotactic and proinflammatory effects and also for the promotion of homeostasis. MIP-1α is synthesised as a 92 amino acid precursor that is proteolytically processed to a mature protein of about 70 amino acids. MIP-1α has roles in inflammatory responses at sites of injury or infection by recruiting proinflammatory cells.

Ordering Information


Cat. NumberDescriptionKit Size
EV3680Cytokine Array III Evidence180 Biochips
EV3678Cytokine Array III Evidence Investigator54 Biochips

Cytokine Array IV (5-plex)

  • MMP-9
  • sIL-2Rα
  • sIL-6R
  • sTNFR I
  • sTNFR II

Matrix metalloproteinase-9 (MMP-9) (gelatinase B) (92 kDa) is a member of the matrix metalloproteinase (MMP) family. MMP-9, one of the most widely investigated MMPs, regulates pathological remodeling processes that involve inflammation and fibrosis.

Soluble IL-2 receptor α (sIL-2Rα) results from the proteolytic cleavage of IL-2Rα at the cell surface by a membrane metalloproteinase; which is encoded by IL2RA on human chromosome. It’s widely noted in research that sIL-2Rα has been found in diseases caused by infections, autoimmune disease and organ transplantation.

Interleukin-6 (IL-6) is a multifunctional cytokine that regulates pleiotropic roles in immune regulation, inflammation, hematopoiesis, and oncogenesis. The IL-6 receptor complex belongs to the haematopoietic receptor superfamily and mediates the biological activities of IL-6. It consists of two distinct membrane bound glycoproteins, an 80 kDa cognate receptor subunit (IL-6R) and a 130 kDa signal-transducing element (gp130). The gp130 subunit is expressed in almost all organs including heart, kidney, spleen, liver, lung, placenta and brain.

Tumour necrosis factor receptor I is one of two specific, high affinity cell surface receptors that function as transducing elements, providing the intracellular signal for cell responses to tumour necrosis factor (TNF). TNF is a proinflammatory cytokine mainly produced by stimulated monocytes, macrophages and T-lymphocyte subsets. It has a key role in host defence and immunosurveillance, mediating complex cellular responses of a different, even contrasting nature. TNFRI has a molecular mass of 55 kDa1 and is expressed by almost all cell types2 especially those cells that are susceptible to the cytotoxic action of TNFI. TNFRs are detectable in normal serum, but their concentration increases significantly in inflammatory and non-inflammatory diseases.

Tumour necrosis factor receptor II (TNFRII) is one of two specific, high affinity cell surface receptors that function as transducing elements, providing the intracellular signal for cell responses to tumour necrosis factor (TNF). TNF is a proinflammatory cytokine mainly produced by stimulated monocytes, macrophages and T-lymphocyte subsets. It has a key role in host defence and immunosurveillance, mediating complex cellular responses of a different, even contrasting nature. TNFRII has a molecular mass of 75 kDa1. Although TNFRII is expressed by almost all cell types, it is expressed primarily by cells of the immune system, cells of myeloid origin and endothelial cells.

Ordering Information


Cat. NumberDescriptionKit Size
EV3659Cytokine Array IV Evidence180 Biochips
EV3661Cytokine Array IV Evidence Investigator54 Biochips

Cytokine Array V (5-plex)

  • IL-3
  • IL-7
  • IL-12p70
  • IL-13
  • IL-23

Interleukin-3 (IL-3) possesses diverse biological activities and was discovered independently in studies on its biological activities. IL-3 is a heavily glycosylated protein with a polypeptide chain of 133 amino acids. It occurs naturally in a diversity of glycoforms generated by the addition of carbohydrate groups which results in size heterogeneity from 28 to 45 kDa. The function of the extensive carbohydrate modifications of the IL-3 polypeptide is not known however IL-3 has been linked with various diseases including colorectal and pancreatic cancers.

Interleukin-7 (IL-7) is classified as a type 1 short-chain cytokine of the haematopoietin family, a group that also includes IL-2, IL-3, IL-4, IL-5, GM-CSF, IL-9, IL-13, IL-15, M-CSF, and stem cell factor. The human gene for IL-7 is located on chromosome 8q12-13. The amino acid sequence of IL-7 predicts a molecular weight of 17.4 kDa, but glycosylation results in an active protein of 25 kDa. IL-7 appears to be involved in the development of an effective immune system and also in the generation and maintenance of strong and effective cellular immune responses directed against cancer cells, or infectious diseases.

Interleukin-12 (IL-12) is a 75 kDa heterodimeric glycoprotein cytokine composed of disulphide linked p40 (40 kDa) and p35 (35 kDa) subunits that are derived from separate genes1. p35 is expressed in a limiting and tightly regulated fashion by many different cell types, however the expression of p40, though in greater quantities than required for p70 formation, appears to be restricted to antigen presenting cells. IL-12 stimulates IFN production, which is essential in resistance to intracellular protozoan, fungal and bacterial infections and, in addition, tumours. Traditionally, IL-12 is accepted as an important mediator of autoimmunity and is involved in a number of autoimmune diseases including rheumatoid arthritis, psoriasis, inflammatory bowel disease and insulin-dependent diabetes mellitus.

Interleukin-13 (IL-13) is a 12 kDa protein that folds into four I-helical bundles. It contains four potential N-glycosylation sites and four cysteine residues that form two intramolecular disulphide bonds. IL-13 shares a number of structural features and functional characteristics with IL-4. The IL-13 protein is approximately 25% homologous1 with IL-4 and belongs to the same I-helix protein family. IL-13 plays a dominant role in resistance to most gastrointestinal nematodes and also modulates resistance to intracellular organisms by regulating cell mediated immunity. IL-13 is the central mediator of allergic asthma, where it regulates eosinophilic inflammation, mucus secretion, and airway hyperresponsiveness. Although IL-13 is associated primarily with the induction of airway disease, it also has anti-inflammatory properties.

Interleukin 23 (IL-23) is member of the IL-12 family. The IL-12 family consists of cytokines IL-12(p40p35), IL-23(p40p19) and IL-27(EBI13p28), and monomeric and homodimeric p401. IL-23 is a heterodimeric cytokine composed of disulphide linked p19 and p40 subunits. IL-23 plays a role in a signaling pathway that triggers inflammation.

Ordering Information


Cat. NumberDescriptionKit Size
EV3666Cytokine Array V Evidence Investigator54 Biochips

Immunoassay Platforms

Want to know more?

Contact us or visit our COVID-19 Monitoring & Management page

Related Products

Cytokine Array I Control

Cytokine Array I High Sensitivity Control

Cytokine Array III Control

Cytokine Array IV Control

Randox Discovery

Randox Discovery | The Benchtop Lab

Discover The Future Of Molecular & Immunoassay Diagnostics

Why Choose the Discovery?

  • null
    The Discovery is an exciting and disruptive analyser capable of molecular and immunoassay testing
  • null
    Simultaneous detection of hundreds of targets from a single patient sample via patented biochip technology
  • null
    Flexible test menu comprising immunoassay and genetic tests for infectious diseases & oncology
  • null
    Rapid turnaround time. Three hours to first batch of results with results for subsequent batches every hour after
  • null
    Fully automated platform increasing operator walkaway time.  A single operator is all that’s required to run up to 3 Discovery analysers
  • null
    Simple and easy to use. Intuitive user interface guides the operator through the entire testing process

Discover The Power Of Automation

Randox Discovery is comprised of three interconnected modules which each  operate independently performing different aspects of the diagnostic testing process. Each module is separated by a physical barrier to prevent contamination and is accessible via a door. The workflow process runs from right to left and is compatible with lean working principles.

  • Module I
  • Module II
  • Module III

Nucleic Acid Extraction

Module I is responsible for DNA/RNA extraction. After extraction the sample is automatically transferred to Module II. Before transfer, Module I detects the presence of Module II cartridges using a unique vision system.

Multiplex PCR

Module II is responsible for amplification of the extracted nucleic acid by End-Point PCR. UV light is used to sterilise the module and reduce the risk of crossover contamination.

Biochip Hybridisation & Detection

Module III is used in both immunoassay & molecular workflows and is responsible for hybridisation and subsequent detection using patented biochip technology. The detection camera uniquely moves between sample cartridges to detect biochip chemiluminescence.

Discover the Power of Randox Biochip Technology


The Randox Discovery is an exciting and disruptive molecular & immunoassay diagnostic analyser capable of consolidating the normal workload of multiple laboratories, into one compact benchtop platform. Randox patented Biochip Technology allows simultaneous detection of hundreds of targets from a single patient sample.  The benefits of multiplexing in this way are endless; allows complete patient profiling, reduces the amount of time spent on individual tests, identifies co-infections, differentiates between pathogens that exhibit similar symptoms and eliminates the need to run multiple time consuming and sample intensive assays. The biochip detection system is based on a chemiluminescent signal, this is the emission of light, without heat, as a result of a chemical reaction.

Discover Our Comprehensive Test Menu


  • SARS-CoV-2 Array (COVID-19)
  • Extended Coronavirus Array
  • Molecular Test Menu
  • Immunoassay Test Menu
  • Toxicology Test Menu
SARS-CoV-2 (COVID-19)Sarbecovirus
(SARS, SARS like, SARS-CoV-2)
SARS-CoV-2 (COVID-19)Sarbecovirus
(SARS, SARS like, SARS-CoV-2)
Influenza A
Coronavirus 229E/NL63Adenovirus A/B/C/D/EInfluenza B
Coronavirus OC43/HKUIEnterovirus A/B/C/D / Rhinovirus A/B/CRespiratory Syncytial Virus A/B (RSV)
Middle East Respiratory
Syndrome Coronavirus (MERS-CoV)
Adenovirus A/B/C/D/E

*In Development – Respiratory Tract Infections Array, Chronic Lung Infections Array, Sexually Transmitted Infections Array & Urinary Tract Infections Array, KRAS, BRAF & PIK3CA Array, Familial Hypercholesterolemia Array & Cardiac Risk Array.

*In Development – A number of clinical immunoassay arrays covering a range of disease markers including adhesion molecules, alzheimers, anaemia, bone disease, cancer, cardiac, cytokines, diabetes, endocrines, fibrinolysis, fertility, gastrointestinal, metabolic, renal, stroke, thyroid & tissue damage.

*In Development – A number of clinical toxicology arrays are in development covering a wide range of Drugs of Abuse (DoA) & New Psychoactive Substances (NPS) detecting over 500 drug and drug metabolites using innovative Biochip Technology.

Product availability may vary from country to country. Some product may be for Research use Only. For more information on product application and availability, please contact your local Randox Representative.

Discover Randox’s Molecular Platforms

All In One Point Of Care Molecular Platform

Compact, Semi-Automated Benchtop Analyser

Related Products




Evidence Investigator

The world’s most extensive Drugs of Abuse Test Menu

Randox Toxicology offers the most comprehensive Drugs of Abuse (DoA) test menu across multiple forensic matrices. Our level of expertise in toxicology research and development allows us to adapt quickly to the ever-changing market influences and develop assays for current and novel drugs trends. Excellent assay precision and performance eliminates false reporting, therefore reducing unnecessary confirmatory tests and time lost in the laboratory as a result. Our Biochip Arrays offer CVs typically less than 10%, producing an accurate drug profile to ensure confidence in results.

Buprenorphine Ketamine Oxycodone I
Creatinine LSD Oxycodone II
Fentanyl MDMA Propoxyphene
Generic Opioids Methaqualone

The Evidence Series of immunoassay analysers are powered by Biochip Array Technology and combine the latest technological advances for drug residue detection using immunoassay principles. The Drugs of Abuse II panel is available for both the Evidence and the Evidence Investigator analysers. The Evidence has a throughput of 90 samples per hour, testing up to 44 tests per sample.  The Evidence is a fully automated batch immunoanalyser, allowing for 3960 tests per hour, while the Evidence Investigator is a semi-automated, bench top analyser with testing capabilities of 2376 tests in 70 minutes.



To find out more about our Biochip Array Technology and our Evidence Series analysers, visit, or email us at

Product Spotlight: HbA1c Quality Controls

Randox Quality Contol Logo

Product Spotlight

HbA1c Quality Controls


Diabetes is a life-long condition which occurs when the glucose level in the blood is too high because it can’t enter the body’s cells to be used as fuel. There are two types of diabetes: type 1 and type 2. They are distinct conditions and must be treated and managed differently.

Type 1 Diabetes

Type one diabetes is an autoimmune condition in which the body attacks insulin-producing cells, this causes a lack of insulin, leading to an increased blood glucose level. Around 10% of people with diabetes has type 1.

Type 2 Diabetes

A mixture of genetic and environmental factors causes type 2 diabetes. The body doesn’t make enough insulin or the insulin it does create does not work correctly, leading to a glucose build up in the blood. It’s thought that up to 58% of type 2 diabetes can be prevented or delayed through healthy lifestyle choices.


HbA1c is the average blood glucose level for the past two to tthree months. A high HbA1c means there is too much sugar in the bloodstream. This means the patient is more likely to develop complications associated with diabetes, like problems with feet and eyes [1].

HbA1c in Diagnostics

In 2011, the WHO accepted the use of glycated haemoglobin (HbA1c) testing in the diagnosis of diabetes, Diabetes UK also supports this decsion [2].

HbA1c can be used as a diagnostic test for diabetes providing that stringent quality assurance tests are in place and assays are standardised to criteria aligned to the international reference values, and there are no conditions present which preclude its accurate measurement.”
World Health Organisation (2011)

Clinically Significant Levels

A HbA1c level of 6.5% is recomended as the cut off for diabetes diagnosis [3], this can be seen in Fig. 1.

HbA1c Levels

Fig. 1. Clinically relevant levels for Diabetes diagnosis.

Acusera HbA1c Controls

Acusera HbA1c Quality Control

The Randox Acusera HbA1c control is designed for use in the quality control of both HbA1c and Total Haemoglobin assays. Assayed instrument and method specific target values and ranges are provided for all major systems and methods including HPLC. A reconstituted stability of 4 weeks keeps waste to a minimum and helps to reduce costs.

View HbA1c Control

Acusera Liquid HbA1c Quality Control

Conveniently supplied liquid ready-to-use the Liquid HbA1c control is ideally suited to both clinical laboratories and POCT helping to significantly reduce preparation time. With a stability of 30 days waste and costs are also kept to a minimum.

View Liquid HbA1c Control
Continue Reading

Flu Season

Molecular Respiratory Testing

Contact Us

Product Spotlight Home

Visit the Product spotlight Home to see past product spotlights

  • References

    [1] “What is HbA1c?”, Diabetes UK, 2018. [Online] Availabel:

    [2] Diabetes UK, “Diagnostics criteria for deabetes”, Diabetes UK, 2018. [Online]. Available:

    [3] WHO, “Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus”, World Health Organisation, 2011.

sTfR Quality Control

Therapeutic Drug Quality Control

Providing a true third party solution for the measurement of Soluble Transferrin Receptor (sTfR), the Acusera sTfR Control  will deliver an unbiased, independent assessment of analytical performance.

Designed for use with sTfR assays, this handy single analyte control saves money on wasted material.

Features & Benefits

  • Lyophilised control
  • Human based material
  • Assayed target values available
  • Stable to expiry date at 2°C to 8°C
  • Reconstituted stability of 30 days at 2°C to 8°C
DescriptionSizeAnalytesCat No
sTfR Control (Bi-level)3 x 2 x 1 ml1TF10162
sTfR Calibrator6 x 1 ml1TF10161


  • Soluble Transferrin Receptor (sTfR)

Related Products

Protected: QCMD – Molecular External Quality Control (NEW)

This content is password protected. To view it please enter your password below:

Product Spotlight: Respiratory Controls – Molecular Infectious Disease Testing

Randox Quality Contol Logo

Product Spotlight

Molecular Controls for Respiratory Infection Testing

Respiratory Infections

Flu is a contagious respiratory illness cause by influenza viruses that infect the throat, nose, and sometimes lungs. It can cause illness and sometimes death. Getting vaccinated is the best way to prevent catching flu [1].

There are four types of seasonal flu, A, B, C, and D. Types A and B cause seasonal epidemics of disease. Illnesses range from severe to mild and can even result in death in high risk groups. High risk groups include, pregnant women, children under 5 years of age, the elderly, and people with chronic or immunosuppressive medical conditions [2].

Flu season begins as early as October, reaches its peak in February, and ends in March. In the southern hemisphere, flu season falls between June and September. Wherever it’s cold, it’s flu season.

Diagnosing Flu

A test to detect Influenza viruses can be used to determine whether a patient has the flu. A swab is taken from either the nose or back of the throat and sent for testing. Molecular assays can be used to detect genetic material of the virus [3]. Molecular methods play an important role in the diagnosis and surveillance of influenza viruses. Molecular diagnostics allow timely and accurate detection of influenza and are already implemented in many laboratories. The combination of automated purification of nucleic acids with real-time PCR should enable even more rapid identification of viral pathogens such as influenza viruses in clinical material [4].

Learn more about Flu Season
Qnostics - Molecular Controls for Infectious Disease Testing

The Qnostics range of complete molecular controls for infectious disease testing can be used in the daily monitoring of assay performance, linearity assessment, assay evaluation, validation/verification of new assays and staff training. As whole pathogen controls, the range is designed to mimic the performance of patient samples and can be used to effectively monitor the entire testing process including extraction, amplification and detection.

Qnostics offers a range of solutions for molecular respiratory testing:

Q Controls

Independently manufactured, these positive and externally run controls are designed to be treated as a patient sample within an assay run. Helping to support a laboratory’s accreditation requirements in line with ISO 15189:2012, Q Controls are supplied in an unassayed, liquid frozen format delivering accurate and reliable test results.

Analytical Q Panels

Each Analytical Q Panel consists of five or more individual samples including a negative and is designed to cover the dynamic range of individual infectious disease assays, in a linear progression. Analytical Q Panels are intended for use in the validation and verification of new assays with the main purpose of helping to ensure assays are linear throughout the dynamic range. In addition, Analytical Q Panels will support a laboratory’s accreditation requirements, in line with ISO 15189:2012.

Evaluation Panels

Evaluation Panels may be used to evaluate assay characteristics, confirm performance claims and ultimately ensure the assay is fit for purpose. Evaluation Panels may also be used in the validation of clinical assays and the development of diagnostic tests.

Learn more about Qnostics Respiratory Testing
Continue Reading

Flu Season

Molecular Respiratory Testing

Contact Us

Product Spotlight Home

Visit the Product spotlight Home to see past product spotlights

  • References

    [1] “Key Facts About Influenza (Flu) | Seasonal Influenza (Flu) | CDC”,, 2018. [Online]. Available: [Accessed: 25- Sep- 2018].

    [2] “Influenza (Seasonal)”, World Health Organization, 2018. [Online]. Available: [Accessed: 27- Sep- 2018].

    [3] “Diagnosing Flu | Seasonal Influenza (Flu) | CDC”,, 2018. [Online]. Available: [Accessed: 25- Sep- 2018].

    [4] J. Ellis and M. Zambon, “Molecular diagnosis of influenza”, Reviews in Medical Virology, vol. 12, no. 6, pp. 375-389, 2002.

Product Spotlight: Acusera Cardiac Quality Control

Product spotlight - Cardiac Quality Control Solutions
Cardiac Quality Control Solutions

For this month’s product spotlight, we have chosen our whole range of cardiac quality control solutions. Randox offers options for both Internal Quality Control (IQC) and External Quality Assessment (EQA).

29th September is World Heart Day. World Heart Day is a global campaign during which individuals, families, communities and governments around the world participate in activities to take charge of their heart health and that of others.

Cardiovascular disease (CVD) is a term to describe conditions that affect the heart and blood vessels. It is normally associated with a build up of fatty deposits in the arteries and an increased risk of blood clots. CVD is the leading casues of death globally, representing around 30% of all deaths. A healthy lifestyle can help prevent CVD; however, increasingly busy lifestyles mean that it is difficult to avoid CVD. This means it is vitally important that individuals are tested for CVD and to ensure that diagnoses are acurate.

Acusera Internal Quality Controls

The accurate diagnosis of a potentially life threatening cardiac event is essential in order to avoid misdiagnosis and/or incorrect treatment. The Acusera Cardiac Quality Controls have been designed to cover a wide range of cardiac markers at clinical decision levels eliminating the need for additional low level controls at extra expense. Available in a choice of both liquid ready-to-use and lyophilised formats, they are ideal for use at the point-of-care and in the laboratory. Manufactured from 100% human serum a matrix similar to that of the patient is guaranteed.

  • Liquid Controls

    Control Vial

    Liquid Cardiac Control

    Liquid, Assayed, 100% Human serum
    8 Analytes

    Control Vial

    BNP Control

    Liquid, Assayed, 100% Human serum
    1 Analyte

  • Lyophilised Controls

    Control Vial

    Cardiac Control

    Lyophilised, Assayed, 100% Human serum
    7 Analytes

    CK-MB Control

    Lyophilised, Assayed, 100% Human serum
    2 Analytes

    Control Vial

    H-FABP Control

    Lyophilised, Assayed, 100% Human serum
    1 Analyte

    hsTnT Control

    Lyophilised, Assayed, 100% Human serum
    1 Analyte

RIQAS External Quality Assessment

The RIQAS Cardiac EQA programme is designed to monitor the performance of up to 7 clinically significant cardiac markers. Two flexible reporting options are available to suit the needs of all laboratory sizes.

Accredited to ISO/IEC 17043

•  Lyophilised for enhanced stability
•  100% human serum
•  Bi-weekly reporting
•  Submit results and view reports online via RIQAS.Net
•  Register up to five instruments at no extra cost


CK, Total | CK-MB activity units | CK-MB mass units | Homocysteine | Myoglobin | Troponin I | Troponin T

Continue Reading

Cardiac Controls

Cardiac EQA

Contact Us

Product Spotlight Home

Visit the Product spotlight Home to see past product spotlights

Request a meeting
Make an Enquiry - RX series
Make an Enquiry - Reagents
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
Make an Enquiry - Reagents
Make an Enquiry - Quality Control
Make an Enquiry - RIQAS
Make an Enquiry - RIQAS
Make an Enquiry - Quality Control
Make an Enquiry
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
Make an Enquiry - Biochip
  • This field is for validation purposes and should be left unchanged.
Make an Enquiry - Molecular